Description
Indications
OLADX ADP- (PARP) , • BRCA FDA OLADX • , (HRD) , • BRCA , / • FDA OLADX • BRCA , FDA OLADX • gBRCAm 2 (HER2) FDA OLADX • gBRCAm HER2 (HR) FDA OLADX • gBRCAm , 16 FDA OLADX • (HRR) (mCRPC) , FDA OLADX • BRCA (BRCAm) (mCRPC) FDA OLADX
How It Works
12.1 How It Works ADP- PARP , PARP1 PARP2 PARP3 PARP , DNA DNA , , , , BRCA1/2 ATM DNA HRR , , , PARP1 PARP2 PARP3
Pharmacology
12 12.1 How It Works ADP- PARP , PARP1 PARP2 PARP3 PARP , DNA DNA , , , BRCA1/2 ATM DNA HRR , , , PARP PARP-DN
Dosage
• , 300mg, • OLADX mCRPC (GnRH) , • CLcr 31-50 mL/min , OLADX , 200mg
Precautions
5 Precautions • / (MDS/AML) Lynparza BRCA γ BRCA HRR HRD , 1.2% MDS/AML, MDS/AML, (5.1) • Lynparza ,1.0% , , ,
Drug Interactions
7 • CYP3A , Lynparza (2.4, 7.2, 12.3) • CYP3A (7.2, 12.3) 7.1 Lynparza DNA , 7.2 Lynparza CYP3A CYP3A , [ (12.3)]



